In September 1997, the anti-obesity drugs Pondimin and Redux, ingredients in the popular drug combination fen … how consumers respond to drug withdrawals. In theory, remaining drugs in the therapeutic class could enjoy competitive … benefits, or suffer negative spillovers, from the withdrawal of a competing drug. Our findings suggest that, while the …